Koya Medical Competitors and Similar CompaniesClear all

Koya Medical's competitors and similar companies include Hemarina, PolarityTE, Quantum-Si and Sangon Biotech.

	Koya Medical Koya Medical is a healthcare company focused on advancing lymphatic and venous care.	Hemarina Hemarina is a biotechnology company centered on the research and development of marine oxygen carriers for therapeutic and industrial applications.	PolarityTE PolarityTE, Inc. is a regenerative medicine company positioned to be the first to successfully regenerate human skin.	Quantum-Si Quantum-Si Incorporated (QSI) is a biotechnology company that provides protein sequencing technology solutions.	Sangon Biotech Sangon Biotech (Shanghai) (生工生物工程(上海)股份有限公司) is a biotechnology company engaged in the research and development of chemical synthesis of DNA.
Founding Date	Founding Date 2018	Founding Date N/A	Founding Date 1986	Founding Date 2013	Founding Date 1995
Type	Type Private	Type Private	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech healthtech	Tags Healthcare biotech healthtech	Tags Healthcare biotech healthtech	Tags Healthcare biotech healthtech	Tags Healthcare biotech healthtech
Locations	Locations Oakland, US HQ	Locations Morlaix, FR HQ	Locations Salt Lake City, US HQ Salt Lake City, US	Locations Branford, US HQ	Locations Shanghai, CN HQ
Employees	Employees 1193% increase	Employees 186	Employees 15627% increase	Employees 16518% decrease	Employees 69
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 1.8 m	Valuation ($) 109.7 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $814k (FY, 2022)	Revenue (est.) $3.1m (FY, 2024)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $616k (FY, 2022)	Cost of goods $1.5m (FY, 2024)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $198k (FY, 2022)	Gross profit $1.6m (FY, 2024)	Gross profit N/A
Net income	Net income N/A	Net income N/A	Net income ($7.8m) (FY, 2022)	Net income ($101m) (FY, 2024)	Net income N/A
Funding
Latest funding round	Latest funding round $ 26m (about 3 years ago)	Latest funding round $ 3.7m (over 14 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 26m	Total funding raised $ 4.8m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 6.2m